Elsevier to Contribute 9 Million Articles to Cr...

AMSTERDAM, June 23 /PRNewswire/ --

    - Ready to Implement CrossRef's Plagiarism Detection Software After
Successful Pilot



    Elsevier, the leading publisher of science, technology and medical
information announced today that it will implement CrossCheck, the plagiarism
detection service offered by CrossRef in collaboration with iParadigms. With
plagiarism a growing problem for journal editors, Elsevier has invested in
CrossCheck to develop, pilot and implement, a single database of published
articles enabling publishers to easily verify the originality of submitted
and published work.



    After a successful six months pilot with eight leading publishers,
Elsevier is now in the process of integrating CrossCheck into its editorial
workflows as part of its efforts to support the peer review process and
assist the scientific community in all aspects of publishing ethics. Elsevier
will contribute nearly nine million journal articles to the CrossCheck
database, which is launching with a commitment of over 20 million journal
articles from publishers including the Association for Computing Machinery,
American Society of Neuroradiology, BMJ Publishing Group, Elsevier, Institute
of Electrical & Electronics Engineers, International Union of Crystallography
, The Journal of the American Medical Association, Nature Publishing Group,
Oxford University Press, Sage, Informa UK (Taylor & Francis), and Wiley
Blackwell.



    "By creating a pooled database of articles from multiple publishers and
tested tools, we can provide assistance to the scholarly community on an
unprecedented scale," commented Martin Tanke, Elsevier's Managing Director of
S&T Journal Publishing, "CrossRef has taken the principles of publisher
collaboration far beyond reference linking. CrossCheck, combined with our
recently launched Publishing Ethics Resource Kit and full journal membership
in COPE (Committee on Publishing Ethics) further reinforce our commitment."



    "CrossRef took the initiative to create this co-operative publisher
service, which we greatly appreciate. This is a tremendous development and we
are delighted that this collaboration has been so fruitful," said Karen
Hunter, Senior Vice President Global Academic & Customer Relations and
Elsevier's CrossRef Board member, "The iParadigms software is impressive and
we are look forward to working with them."



    John Barrie, Ph.D, president and CEO of iParadigms, LLC added, "Our
customers, especially academic ones, have been asking for more medical and
science content for checking the originality of work destined for
publication. Elsevier's adoption of CrossCheck powered by iThenticate lets us
leverage their vast, industry-leading content to significantly enhance the
effectiveness of our originality checking services. Likewise, Elsevier will
leverage the CrossCheck and iParadigms database which makes for a powerful
alliance and one that is extremely beneficial to our network of institutional
subscribers."



About Elsevier

    Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over 70
offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult (
http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.



    Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).



    
    Contact:
    Ylann Schemm,
    Phone: [phone],
    E-mail: [e-mail]